To use all functions of this page, please activate cookies in your browser.
My watch list
my.bionity.com
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Last viewed
- BioTek Introduces New General Manager in Germany
- Micromets BiTE-Antikörper Blinatumomab scheint zur Konsolidierungstherapie von Patienten mit aggressiven Leukämien geeignet - Zwischenauswertung der Phase-2-Studie zur Behandlung von Patienten mit akuter B-Zell lymphoblastischer Leukämie zeigt, dass Blinatumomab minimale Resterkrankung erfolgreich bekämpfen kann
- Otti_Wilmanns
- Laura_Schlessinger
- New approach for targeted cancer immunotherapy - Novel immunotherapy, based on a locally focused activation of immune cells, could help to more efficiently eradicate tumor cells and reduce side effects
